234 related articles for article (PubMed ID: 15378428)
1. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
2. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
[TBL] [Abstract][Full Text] [Related]
3. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
Baeten JM; Lingappa J; Beck I; Frenkel LM; Pepper G; Celum C; Wald A; Fife KH; Were E; Mugo N; Sanchez J; Essex M; Makhema J; Kiarie J; Farquhar C; Corey L
J Infect Dis; 2011 Jan; 203(1):117-21. PubMed ID: 21148504
[TBL] [Abstract][Full Text] [Related]
5. Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial.
Tan DH; Raboud JM; Kaul R; Grinsztejn B; Cahn P; Walmsley SL
Trials; 2010 Nov; 11():113. PubMed ID: 21106086
[TBL] [Abstract][Full Text] [Related]
6. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
Watson-Jones D; Weiss HA; Rusizoka M; Changalucha J; Baisley K; Mugeye K; Tanton C; Ross D; Everett D; Clayton T; Balira R; Knight L; Hambleton I; Le Goff J; Belec L; Hayes R; ;
N Engl J Med; 2008 Apr; 358(15):1560-71. PubMed ID: 18337596
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.
Tobian AA; Grabowski MK; Serwadda D; Newell K; Ssebbowa P; Franco V; Nalugoda F; Wawer MJ; Gray RH; Quinn TC; Reynolds SJ;
J Infect Dis; 2013 Sep; 208(5):839-46. PubMed ID: 23812240
[TBL] [Abstract][Full Text] [Related]
8. Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.
Barnabas RV; Celum C
Curr HIV Res; 2012 Apr; 10(3):228-37. PubMed ID: 22384842
[TBL] [Abstract][Full Text] [Related]
9. High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.
Mujugira A; Huang ML; Selke S; Drolette L; Magaret AS; Wald A
Sex Transm Dis; 2015 Dec; 42(12):705-9. PubMed ID: 26562701
[TBL] [Abstract][Full Text] [Related]
10. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
Watson-Jones D; Wald A; Celum C; Lingappa J; Weiss HA; Changalucha J; Baisley K; Tanton C; Hayes RJ; Marshak JO; Gladden RG; Koelle DM
J Clin Microbiol; 2010 Oct; 48(10):3496-503. PubMed ID: 20702659
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of atypical presentations of mucocutaneous herpes simplex virus infection observed in immunosuppressed individuals. Part II: the knife-cut sign.
Cohen PR
Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762853
[TBL] [Abstract][Full Text] [Related]
12. Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial.
Nakubulwa S; Kaye DK; Bwanga F; Tumwesigye NM; Nakku-Joloba E; Mirembe F
Reprod Health; 2017 Mar; 14(1):31. PubMed ID: 28253893
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.
Devanand DP; Andrews H; Kreisl WC; Razlighi Q; Gershon A; Stern Y; Mintz A; Wisniewski T; Acosta E; Pollina J; Katsikoumbas M; Bell KL; Pelton GH; Deliyannides D; Prasad KM; Huey ED
BMJ Open; 2020 Feb; 10(2):e032112. PubMed ID: 32034019
[TBL] [Abstract][Full Text] [Related]
14. An unusual co-reactivation of herpes genitalis and shingles in a young male with primary genital herpes in partner.
Sadhukhan S; Patra S; Gadepalli R; Kaur M
Int J STD AIDS; 2024 May; 35(6):487-489. PubMed ID: 38261739
[TBL] [Abstract][Full Text] [Related]
15. Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.
Gianella S; Redd AD; Grabowski MK; Tobian AA; Serwadda D; Newell K; Patel EU; Kalibbala S; Ssebbowa P; Gray RH; Quinn TC; Reynolds SJ
J Infect Dis; 2015 Sep; 212(6):899-903. PubMed ID: 25743428
[TBL] [Abstract][Full Text] [Related]
16. Genital HSV detection among HIV-1-infected pregnant women in labor.
Patterson J; Hitti J; Selke S; Huang ML; Watts DH; Brown Z; Corey L; Wald A
Infect Dis Obstet Gynecol; 2011; 2011():157680. PubMed ID: 21527986
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis.
Aribi Al-Zoobaee FW; Yee Shen L; Veettil SK; Gopinath D; Maharajan MK; Menon RK
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265920
[TBL] [Abstract][Full Text] [Related]
18. Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women.
Redd AD; Newell K; Patel EU; Nalugoda F; Ssebbowa P; Kalibbala S; Frank MA; Tobian AA; Gray RH; Quinn TC; Serwadda D; Reynolds SJ
Sex Transm Infect; 2015 Nov; 91(7):485-8. PubMed ID: 25904747
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of atypical presentations of mucocutaneous herpes simplex virus infection observed in immunosuppressed individuals. Part I: herpetic geometric glossitis.
Cohen PR
Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762852
[TBL] [Abstract][Full Text] [Related]
20. Atypical genital herpes: report of five cases.
Uusküla A; Raukas E
Scand J Infect Dis; 2004; 36(1):37-9. PubMed ID: 15000557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
